Naloxone: a limited clinical role
Clinical guidance allows consideration of naloxone in marked sedation or coma, particularly with respiratory depression. The overall response in DXM intoxication remains unpredictable.
CorrectedAccording to the 2026 audit · edition
Evidence and limitations
What was examined: Chyka’s consensus guideline assigns this recommendation Grade C. It addresses poisoning management and patient referral.
Limits of the conclusion: Use belongs within medical care. This section explains the evidence without providing a self-treatment protocol.
Sources: Chyka — clinical poisoning guideline
Historical paraphrase · FAQ 4.0 · 1997 · §6.10 The FAQ presents intravenous naloxone as an antidote for DXM poisoning.
This claim in the 2026 audit · Erowid archive (HTML 4.0-Y.1) · §6.10 · How Toxic is DXM, and What is the Lethal Dose?